Definium Therapeutics (DFTX) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $34.26, +0.06% vs the prior close of $34.24.
- Volume 1.75M shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
DFTX ends flat (+0.1%) to $34.26. Closed at $34.26, +0.06% vs the prior close of $34.24. Day range $33.92–$34.79, opened at $34.23.
DFTX daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — DFTX ends flat (+0.1%) to $34.26
- Closed at $34.26, +0.06% vs the prior close of $34.24. Day range $33.92–$34.79, opened at $34.23.
- Volume was 1.75M shares, 0.8x its 50-day average of 2.27M.
- Price is -13.8% vs its 50-day average ($39.73) and +20.6% vs its 200-day average ($28.41).
- 52-week range $10.47–$49.70; today's close sits at 61% of that range, 31.1% below the 52-week high.
Oct 14, 2026 — DFTX dips 0.4% to $34.24, 3 down days in a row
- Closed at $34.24, -0.41% vs the prior close of $34.38. Day range $33.65–$34.91, opened at $34.20.
- Volume was 1.76M shares, 0.8x its 50-day average of 2.28M.
- Price is -14.2% vs its 50-day average ($39.93) and +21.0% vs its 200-day average ($28.30).
- 52-week range $10.47–$49.70; today's close sits at 61% of that range, 31.1% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — DFTX dips 2.3% to $34.38
- Closed at $34.38, -2.33% vs the prior close of $35.20. Day range $34.03–$34.95, opened at $34.83.
- Volume was 2.00M shares, 0.9x its 50-day average of 2.27M.
- Price is -14.2% vs its 50-day average ($40.09) and +21.9% vs its 200-day average ($28.20).
- 52-week range $10.47–$49.70; today's close sits at 61% of that range, 30.8% below the 52-week high.
Oct 12, 2026 — DFTX slides 4.6% to $35.20
- Closed at $35.20, -4.61% vs the prior close of $36.90. Day range $34.95–$36.30, opened at $36.27.
- Volume was 1.91M shares, 0.8x its 50-day average of 2.28M.
- Price is -12.5% vs its 50-day average ($40.24) and +25.3% vs its 200-day average ($28.09).
- 52-week range $10.47–$49.70; today's close sits at 63% of that range, 29.2% below the 52-week high.
Oct 9, 2026 — DFTX jumps 8.0% to $36.90
- Closed at $36.90, +7.96% vs the prior close of $34.18. Day range $34.57–$38.04, opened at $34.85.
- Volume was 2.77M shares, 1.2x its 50-day average of 2.26M.
- Price is -8.7% vs its 50-day average ($40.40) and +31.8% vs its 200-day average ($27.99).
- 52-week range $10.47–$49.70; today's close sits at 67% of that range, 25.8% below the 52-week high.
Oct 8, 2026 — DFTX dips 2.6% to $34.18, a 3-month low, 8 down days in a row
- Closed at $34.18, -2.59% vs the prior close of $35.09. Day range $32.84–$34.88, opened at $34.62.
- Volume was 2.10M shares, 0.9x its 50-day average of 2.25M.
- Price is -15.7% vs its 50-day average ($40.56) and +22.6% vs its 200-day average ($27.87).
- 52-week range $10.47–$49.70; today's close sits at 60% of that range, 31.2% below the 52-week high.
- That makes 8 straight losses.
Oct 7, 2026 — DFTX dips 1.5% to $35.09, a 3-month low, 7 down days in a row
- Closed at $35.09, -1.49% vs the prior close of $35.62. Day range $34.92–$36.38, opened at $35.34.
- Volume was 1.97M shares, 0.9x its 50-day average of 2.25M.
- Price is -13.8% vs its 50-day average ($40.72) and +26.4% vs its 200-day average ($27.76).
- 52-week range $10.47–$49.70; today's close sits at 63% of that range, 29.4% below the 52-week high.
- That makes 7 straight losses.
Oct 6, 2026 — DFTX dips 1.7% to $35.62, a 3-month low, 6 down days in a row
- Closed at $35.62, -1.68% vs the prior close of $36.23. Day range $34.38–$36.55, opened at $36.55.
- Volume was 2.48M shares, 1.1x its 50-day average of 2.23M.
- Price is -12.8% vs its 50-day average ($40.85) and +28.8% vs its 200-day average ($27.65).
- 52-week range $10.47–$49.70; today's close sits at 64% of that range, 28.3% below the 52-week high.
- That makes 6 straight losses.
Oct 5, 2026 — DFTX slides 3.1% to $36.23, 5 down days in a row
- Closed at $36.23, -3.13% vs the prior close of $37.40. Day range $35.90–$37.74, opened at $37.50.
- Volume was 2.60M shares, 1.2x its 50-day average of 2.20M.
- Price is -11.6% vs its 50-day average ($40.99) and +31.6% vs its 200-day average ($27.53).
- 52-week range $10.47–$49.70; today's close sits at 66% of that range, 27.1% below the 52-week high.
- That makes 5 straight losses.
Oct 2, 2026 — DFTX dips 0.5% to $37.40, 4 down days in a row
- Closed at $37.40, -0.53% vs the prior close of $37.60. Day range $36.86–$38.14, opened at $37.70.
- Volume was 1.60M shares, 0.7x its 50-day average of 2.18M.
- Price is -9.1% vs its 50-day average ($41.13) and +36.4% vs its 200-day average ($27.41).
- 52-week range $10.47–$49.70; today's close sits at 69% of that range, 24.7% below the 52-week high.
- That makes 4 straight losses.
DFTX latest news & SEC filings
Every SEC filing by or about DFTX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Karlin Daniel sold 10,853 shares at $36.57 (≈$396.89K) on Sep 25, 2026; now holds 792,846
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Barrow Robert sold 31,550 shares at $36.57 (≈$1.15M) on Sep 25, 2026; now holds 2,213,090
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Wiley Matthew T. sold 3,097 shares at $36.57 (≈$113.26K) on Sep 25, 2026; now holds 359,036
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Sullivan Mark sold 14,051 shares at $36.57 (≈$513.85K) on Sep 25, 2026; now holds 494,228
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Roberts Brandi sold 3,377 shares at $36.57 (≈$123.50K) on Sep 25, 2026; now holds 394,528
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 25, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Sep 8, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 12, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 — Reported other events the company considers important.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$158.99M (prior year -$42.74M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$1.44 (prior year -$0.50) (loss widened vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 8.01 — Reported other events the company considers important.
Jun 24, 2026 · Form 424B5 — Prospectus supplement
Prospectus supplement — the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Things to know before you trade DFTX
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Feb 26, 2026, Jan 12, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.39% (largest 8.0%).
- Liquidity: about 2.26M shares (≈$77.27M) trade per day on average.
- 52-week position: $34.26 vs a range of $10.47–$49.70 (61% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 17 sales; latest: Robert Barrow sold 31,550 shares on Sep 25, 2026.
- Latest filings: 8-K Sep 14, 2026; 8-K Sep 8, 2026; 8-K Aug 12, 2026.
- Share count: 134.37M shares outstanding (Jul 30, 2026), +76.6% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Medicinal Chemicals & Botanical Products.
DFTX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 34.23 | 34.79 | 33.92 | 34.26 | 1.75M |
| Oct 14, 2026 | 34.20 | 34.91 | 33.65 | 34.24 | 1.76M |
| Oct 13, 2026 | 34.83 | 34.95 | 34.03 | 34.38 | 2.00M |
| Oct 12, 2026 | 36.27 | 36.30 | 34.95 | 35.20 | 1.91M |
| Oct 9, 2026 | 34.85 | 38.04 | 34.57 | 36.90 | 2.77M |
| Oct 8, 2026 | 34.62 | 34.88 | 32.84 | 34.18 | 2.10M |
| Oct 7, 2026 | 35.34 | 36.38 | 34.92 | 35.09 | 1.97M |
| Oct 6, 2026 | 36.55 | 36.55 | 34.38 | 35.62 | 2.48M |
| Oct 5, 2026 | 37.50 | 37.74 | 35.90 | 36.23 | 2.60M |
| Oct 2, 2026 | 37.70 | 38.14 | 36.86 | 37.40 | 1.60M |
| Oct 1, 2026 | 37.94 | 38.95 | 37.29 | 37.60 | 2.12M |
| Sep 30, 2026 | 38.42 | 38.80 | 37.32 | 38.06 | 2.38M |
| Sep 29, 2026 | 38.33 | 38.70 | 37.44 | 38.21 | 1.97M |
| Sep 28, 2026 | 35.92 | 39.10 | 35.51 | 38.41 | 2.99M |
| Sep 25, 2026 | 37.00 | 37.00 | 36.14 | 36.17 | 2.68M |
| Sep 24, 2026 | 37.49 | 37.60 | 35.89 | 36.73 | 2.31M |
| Sep 23, 2026 | 40.03 | 40.04 | 37.17 | 37.65 | 2.71M |
| Sep 22, 2026 | 39.42 | 40.39 | 38.70 | 40.32 | 1.75M |
| Sep 21, 2026 | 39.00 | 39.54 | 37.97 | 39.28 | 2.04M |
| Sep 18, 2026 | 38.67 | 39.04 | 38.10 | 38.81 | 3.21M |
About Definium Therapeutics
Definium Therapeutics (DFTX) is listed on the Nasdaq and classified by the SEC under “Medicinal Chemicals & Botanical Products”. Its business address is in NEW YORK, NY. State of incorporation: British Columbia, Canada. Fiscal year ends December 31. SEC CIK 1813814.
DFTX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Roger Adsett | Director | Jun 15, 2026 |
| Robert Barrow | Chief Executive Officer | Sep 29, 2026 |
| Suzanne Louise Bruhn | Director | Jun 15, 2026 |
| Roger Crystal | Director | Jun 15, 2026 |
| David W Gryska | Director | Jun 15, 2026 |
| Daniel Karlin | Chief Medical Officer | Sep 29, 2026 |
| Andreas Krebs | Director | Sep 18, 2026 |
| Carol A Vallone | Director | Sep 18, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Robert Barrow | Chief Executive Officer | Sep 29, 2026 |
| Daniel Karlin | Chief Medical Officer | Sep 29, 2026 |
| Brandi Roberts | Chief Financial Officer | Sep 29, 2026 |
| Mark Sullivan | Chief Legal Officer | Sep 29, 2026 |
| Matthew T. Wiley | Chief Commercial Officer | Sep 29, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 25, 2026 | Robert Barrow | Sale | 31,550 | $36.57 |
| Sep 25, 2026 | Daniel Karlin | Sale | 10,853 | $36.57 |
| Sep 25, 2026 | Mark Sullivan | Sale | 14,051 | $36.57 |
| Sep 25, 2026 | Brandi Roberts | Sale | 3,377 | $36.57 |
| Sep 25, 2026 | Matthew T. Wiley | Sale | 3,097 | $36.57 |
| Sep 3, 2026 | Robert Barrow | Sale | 19,023 | $37.94 |
| Jun 25, 2026 | Daniel Karlin | Sale | 10,035 | $45.03 |
| Jun 25, 2026 | Brandi Roberts | Sale | 3,013 | $45.03 |
| Jun 25, 2026 | Mark Sullivan | Sale | 13,008 | $45.03 |
| Jun 25, 2026 | Matthew T. Wiley | Sale | 2,867 | $45.03 |
| Jun 25, 2026 | Robert Barrow | Sale | 29,208 | $45.03 |
| Mar 25, 2026 | Mark Sullivan | Sale | 10,702 | $18.47 |
| Mar 25, 2026 | Daniel Karlin | Sale | 8,018 | $18.47 |
| Mar 25, 2026 | Robert Barrow | Sale | 24,431 | $18.47 |
| Dec 26, 2025 | Daniel Karlin | Sale | 5,600 | $13.15 |
DFTX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-183.79M | -2.06 | $-131.56M |
| Dec 31, 2024 | — | $-108.68M | -1.54 | $-79.13M |
| Dec 31, 2023 | — | $-95.73M | -2.44 | $-64.36M |
| Dec 31, 2022 | — | $-56.80M | -1.84 | $-50.14M |
| Dec 31, 2021 | — | $-93.04M | -3.40 | $-45.82M |
Latest balance sheet: total assets $1.11B, total liabilities $194.22M, cash $655.27M (as of Jun 30, 2026).
DFTX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $46.14 |
| May 7, 2026 | 8-K Item 2.02 (results) | $23.20 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $17.29 |
| Jan 12, 2026 | 8-K Item 2.02 (results) | $13.88 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $11.34 |
| Oct 29, 2025 | 8-K Item 2.02 (results) | $12.91 |
| Jul 31, 2025 | 8-K Item 2.02 (results) | $9.09 |
| May 8, 2025 | 8-K Item 2.02 (results) | $6.46 |
| Mar 6, 2025 | 8-K Item 2.02 (results) | $6.61 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $7.52 |
| Aug 13, 2024 | 8-K Item 2.02 (results) | — |
| Aug 12, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Medicinal Chemicals & Botanical Products
Regencell Bioscience (RGC)Trulieve Cannabis (TRLV)Tilray Brands (TLRY)Aurora Cannabis (ACB)Glass House Brands (GLAS)Usana Health Sciences (USNA)Cronos (CRON)Canopy Growth (CGC)Sndl (SNDL)Niagen Bioscience (NAGE)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on DFTX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.